BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 24784378)

  • 1. HDRMC, an accelerated Monte Carlo dose calculator for high dose rate brachytherapy with CT-compatible applicators.
    Chibani O; C-M Ma C
    Med Phys; 2014 May; 41(5):051712. PubMed ID: 24784378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
    Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
    Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
    Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
    Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
    Poon E; Verhaegen F
    Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator.
    Petrokokkinos L; Zourari K; Pantelis E; Moutsatsos A; Karaiskos P; Sakelliou L; Seimenis I; Georgiou E; Papagiannis P
    Med Phys; 2011 Apr; 38(4):1981-92. PubMed ID: 21626931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric assessment of an air-filled balloon applicator in HDR vaginal cuff brachytherapy using the Monte Carlo method.
    Jiang H; Badkul R; Pokhrel D
    J Appl Clin Med Phys; 2018 May; 19(3):101-107. PubMed ID: 29493101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
    Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
    Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of rib and lung heterogeneities on the computed dose to lung in Ir-192 high-dose-rate breast brachytherapy: Monte Carlo versus a treatment planning system.
    Yazdi HS; Shamsaei M; Jaberi R; Shabani HR; Allahverdi M; Vaezzadeh SA
    J Cancer Res Ther; 2012; 8(3):394-8. PubMed ID: 23174721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
    Poon E; Williamson JF; Vuong T; Verhaegen F
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monte carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shielded cylindrical applicator set.
    Lymperopoulou G; Pantelis E; Papagiannis P; Rozaki-Mavrouli H; Sakelliou L; Baltas D; Karaiskos P
    Med Phys; 2004 Nov; 31(11):3080-6. PubMed ID: 15587661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of patient inhomogeneities in oesophageal 192Ir HDR brachytherapy: a Monte Carlo and analytical dosimetry study.
    Anagnostopoulos G; Baltas D; Pantelis E; Papagiannis P; Sakelliou L
    Phys Med Biol; 2004 Jun; 49(12):2675-85. PubMed ID: 15272681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate localization of intracavitary brachytherapy applicators from 3D CT imaging studies.
    Lerma FA; Williamson JF
    Med Phys; 2002 Mar; 29(3):325-33. PubMed ID: 11929015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-specific Monte Carlo-based dose-kernel approach for inverse planning in afterloading brachytherapy.
    D'Amours M; Pouliot J; Dagnault A; Verhaegen F; Beaulieu L
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1582-9. PubMed ID: 21075547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and characterization of a new high-dose-rate brachytherapy Valencia applicator for larger skin lesions.
    Candela-Juan C; Niatsetski Y; van der Laarse R; Granero D; Ballester F; Perez-Calatayud J; Vijande J
    Med Phys; 2016 Apr; 43(4):1639. PubMed ID: 27036563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-second high dose rate brachytherapy Monte Carlo dose calculations with bGPUMCD.
    Hissoiny S; D'Amours M; Ozell B; Despres P; Beaulieu L
    Med Phys; 2012 Jul; 39(7):4559-67. PubMed ID: 22830787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical design.
    Han DY; Webster MJ; Scanderbeg DJ; Yashar C; Choi D; Song B; Devic S; Ravi A; Song WY
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):666-73. PubMed ID: 24751413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of intracavitary applicators in 192Ir-HDR brachytherapy.
    Ye SJ; Brezovich IA; Shen S; Duan J; Popple RA; Pareek PN
    Med Phys; 2004 Jul; 31(7):2097-106. PubMed ID: 15305463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
    Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
    Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the impact of absorbed dose specification, tissue heterogeneities, and applicator heterogeneities on Monte Carlo-based dosimetry of Ir-192, Se-75, and Yb-169 in conventional and intensity-modulated brachytherapy for the treatment of cervical cancer.
    Morcos M; Viswanathan AN; Enger SA
    Med Phys; 2021 May; 48(5):2604-2613. PubMed ID: 33619739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.